Universal and HIV-specific risk factors may drive poor growth and neurodevelopment through a common set of mechanistic pathways, as outlined in Fig.
2, including co-infections, inflammation, enteropathy, anaemia, nutrient deficiencies, epigenetic modifications and toxic stress, ultimately impacting brain development. However, we lack data on many of these pathogenic processes, meaning studies are needed to further our understanding of the pathways within this conceptual framework. Here, we provide some insights that support these mechanisms as potential mediators of the risk factors discussed above.
Direct exposure to opportunistic infections may cause neurotoxicity and impair growth. Congenital CMV infection in particular has been shown to have a profound impact on neurodevelopment, and the outcomes and mechanisms have been reviewed comprehensively elsewhere [
129]. CMV acquisition in early life is very common in sub-Saharan Africa. The impact of CMV on growth and development may be even greater in HEU children and has recently been reviewed [
45•]. Garcia-Knight and colleagues found that CMV viral load in early infancy was negatively associated with weight-for-age and head circumference-for-age
Z scores in both HIV-exposed and HIV-unexposed children in rural Kenya [
130], and Gompels and colleagues found that CMV was associated with growth and early child development in Zambia, particularly amongst those exposed to HIV [
47].
Environmental enteric dysfunction (EED) is an almost ubiquitous subclinical disorder of the small intestine in LMIC. EED is characterised by villous atrophy, impaired gut barrier function, intestinal inflammation and microbial translocation, leading to systemic inflammation [
131]. We have previously hypothesised that EED may be more severe amongst HEU compared to HIV-unexposed children [
132], although a study of Zimbabwean infants at 6 weeks and 6 months of age showed similar levels of intestinal fatty acid binding protein (I-FABP), a marker of enterocyte damage, in HEU and HIV-unexposed infants. However, CRP was consistently higher in HEU compared to HIV-unexposed infants, highlighting that systemic inflammation is greater in the setting of HIV exposure, although the drivers of inflammation remain poorly defined [
133]. Proinflammatory cytokines appear to be upregulated in HEU compared to HIV-unexposed children even at birth, and certain brain maturation processes such as cell migration and axonal growth may be particularly vulnerable to this inflammatory milieu [
111].
A common co-morbidity with stunting is iron deficiency anaemia (IDA). IDA is a major cause of neurodevelopmental impairment [
43] and has been identified as one of the leading causes of years lived with disability in children [
134]. HIV-exposed children have a higher frequency of anaemia than HIV-unexposed children [
135,
136], plausibly driven by exposure to the virus itself and/or exposure to ART [
137]. HIV infection is associated with other micronutrient deficiencies [
52], and similar effects may be seen in HEU children, although data are currently lacking.
Early-life programming may be influenced by the in utero environment, causing DNA methylation and gene expression modifications [
138]. These epigenetic modifications are now understood to have potential biological impact across the lifespan, leading to the theory of the developmental origins of health and disease and may have intergenerational effects [
139]. HIV infection has been shown to lead to epigenome-wide differential DNA methylation in infected individuals [
140]. Additionally, some studies have indicated that maternal HIV infection is associated with epigenetic modifications in neonates, and HIV and ART-exposed children have been found to have reduced DNA methylation in peripheral blood repetitive elements which may have long-term implications [
141]. Further work is needed to understand this area; however, research into HIV-associated neurocognitive disorders (HAND) in adults indicates a role for genetic and epigenetic profiles in predicting vulnerability to the neurological effects of the virus and ART side effects [
142].
Children living in adverse environments are at risk of chronic stress and persistent activation of their physiological stress response—a process known as toxic stress [
143]. This process may act via the hypothalamic–pituitary–adrenal (HPA) axis and immune responses to disrupt healthy brain circuit development, particularly in the prefrontal cortex [
144]. Through this impact on the neuroendocrine–immune (NEI) network, early experiences can fundamentally shape the developing brain architecture [
143]. Early mutual interactions and experiences between children and key adults also shape the developing brain architecture and affect the NEI network [
143]. Maternal physical and psychological illness coupled with a lack of social support may impact on a mother’s ability to provide a safe and secure physical and emotional environment for her infant [
145]. Similarly, growing up in an environment with inadequate stimulation or few early learning opportunities is associated with reduced cognitive development [
146]. Children growing up in families affected by HIV may face multiple adversities that affect the parent–child relationship including parental illness and death, mental illness, and stress from emotional, financial and social pressures [
147].
Ultimately, the risk factors and mechanisms identified here may modulate brain growth and network development. In addition, there may be other risk factors and mechanisms, including those as yet unknown, influencing these children. The in utero period and early postnatal life is a time of substantial brain growth, when extensive neural network development and maturation take place [
7]. The developing brain during this time is particularly sensitive to environmental influences [
148]. Animal models as well as human studies suggest that infection-induced maternal immune activation impacts developing neural circuits [
106]. Studies have indicated that maternal immune activation and induction of proinflammatory cytokines affecting the microbiota–gut–brain axis or eliciting the stress response through the HPA axis result in atypical brain development of the fetus [
107,
149,
150]. Neuroimaging study findings of HEU-associated white matter microstructural changes early in life [
110,
151] suggest abnormal brain development as a potential mechanism for impaired child outcomes.